Transcripts

BridgeBio Pharma (BBIO) earnings call transcripts

Earnings call transcripts for BridgeBio Pharma, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed BridgeBio as entering a multi-launch chapter, with stronger ATTR differentiation, three regulatory reviews, and profitability approaching.

    Aug 10, 2026Confident0.83